Welcome to the AbbVie fourth-quarter 2024 Earnings Conference Call. [Operator instructions] Today's call is also being ...
AbbVie Inc . (NYSE:ABBV) delivered strong financial results for Q4 2024, surpassing analysts' expectations with an earnings per share (EPS) of $2.16, compared to the forecast of $2.06. The company ...
The North Chicago-based drugmaker is relying on newer treatments to make up for falling sales of Humira, its aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback